KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
KESTRA MEDICAL TECHNOLOGIES, LTD.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$29.37+2.13 (+7.82%)
Close on Oct 19, 2026
- Market cap
- $1.72B
- P/E (TTM)
- –
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Jul 31, 2026
Total debt
$72.50M
Long-term debt
Net debt
$3.94M
After $68.56M of cash
Implied interest rate
18.02%
FY2026 interest ÷ average debt
Interest coverage
-17.9×
FY2026 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Kestra Medical Technologies's annual report. Trading prices and yields need FINRA TRACE data.